Cargando…
Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study
BACKGROUND: The majority of primary care patients referred for bowel endoscopy do not have significant colorectal disease (SCD), and are – in hindsight – unnecessarily exposed to a small but realistic risk of severe endoscopy-associated complications. We developed a diagnostic strategy to better exc...
Autores principales: | Elias, Sjoerd G., Kok, Liselotte, de Wit, Niek J., Witteman, Ben J. M, Goedhard, Jelle G., Romberg-Camps, Mariëlle J. L., Muris, Jean W. M., Moons, Karel G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036273/ https://www.ncbi.nlm.nih.gov/pubmed/27666114 http://dx.doi.org/10.1186/s12916-016-0684-5 |
Ejemplares similares
-
Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016) -
Diagnostic accuracy of faecal calprotectin in patients with active
perianal fistulas
por: Stevens, Toer W, et al.
Publicado: (2019) -
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
por: van Rheenen, Patrick F, et al.
Publicado: (2010) -
Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study
por: Blad, Nathalie, et al.
Publicado: (2022) -
Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness
por: Burri, Emanuel, et al.
Publicado: (2014)